Press release
Influenza Vaccines Market Growth by Top Companies, Trends by Types and Application, Forecast to 2026|
Some of the influential Key Player operated in the report are: AstraZeneca CSL GlaxoSmithKline Sanofi Altimmune BionVax FluGen FOLIA BIOTECH Genentech Green Cross Medicago Moderna Therapeutics Novavax Shijiazhuang Yiling Pharmaceutical SK Chemicals UNM Pharma Vaccitech Vaxart Vaxine Pty Visterra
Get PDF Sample Copy of this Report including (Product, Summary, TOC, TOF, Industry analysis)
: https://www.qyresearch.com/sample-form/form/1540857/global-influenza-vaccines-market
As part of competitive analysis, the research study includes exhaustive company profiling of leading players of the global Influenza Vaccines market. All of the segments studied in the report are analyzed based on different factors such as market share, revenue, and CAGR. The analysts have also thoroughly analyzed different regions such as North America, Europe, and the Asia Pacific on the basis of production, revenue, and sales in the global Influenza Vaccines market. The researchers used advanced primary and secondary research methodologies and tools for preparing this report on the global Influenza Vaccines market.
Segmentation by Type:
Trivalent Flu Vaccines, Quadrivalent Flu Vaccines
Segmentation by Application:
Adults, Pediatrics
Table of Contents
Table of Contents
1 Influenza Vaccines Market Overview
1.1 Influenza Vaccines Product Overview
1.2 Influenza Vaccines Market Segment by Type
1.2.1 Trivalent Flu Vaccines
1.2.2 Quadrivalent Flu Vaccines
1.3 Global Influenza Vaccines Market Size by Type (2015-2026)
1.3.1 Global Influenza Vaccines Market Size Overview by Type (2015-2026)
1.3.2 Global Influenza Vaccines Historic Market Size Review by Type (2015-2020)
1.3.2.1 Global Influenza Vaccines Sales Market Share Breakdown by Type (2015-2026)
1.3.2.2 Global Influenza Vaccines Revenue Market Share Breakdown by Type (2015-2026)
1.3.2.3 Global Influenza Vaccines Average Selling Price (ASP) by Type (2015-2026)
1.3.3 Global Influenza Vaccines Market Size Forecast by Type (2021-2026)
1.3.3.1 Global Influenza Vaccines Sales Market Share Breakdown by Application (2021-2026)
1.3.3.2 Global Influenza Vaccines Revenue Market Share Breakdown by Application (2021-2026)
1.3.3.3 Global Influenza Vaccines Average Selling Price (ASP) by Application (2021-2026)
1.4 Key Regions Market Size Segment by Type (2015-2020)
1.4.1 North America Influenza Vaccines Sales Breakdown by Type (2015-2026)
1.4.2 Europe Influenza Vaccines Sales Breakdown by Type (2015-2026)
1.4.3 Asia-Pacific Influenza Vaccines Sales Breakdown by Type (2015-2026)
1.4.4 Latin America Influenza Vaccines Sales Breakdown by Type (2015-2026)
1.4.5 Middle East and Africa Influenza Vaccines Sales Breakdown by Type (2015-2026)
2 Global Influenza Vaccines Market Competition by Company
2.1 Global Top Players by Influenza Vaccines Sales (2015-2020)
2.2 Global Top Players by Influenza Vaccines Revenue (2015-2020)
2.3 Global Top Players Influenza Vaccines Average Selling Price (ASP) (2015-2020)
2.4 Global Top Manufacturers Influenza Vaccines Manufacturing Base Distribution, Sales Area, Product Type
2.5 Influenza Vaccines Market Competitive Situation and Trends
2.5.1 Influenza Vaccines Market Concentration Rate (2015-2020)
2.5.2 Global 5 and 10 Largest Manufacturers by Influenza Vaccines Sales and Revenue in 2019
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Influenza Vaccines as of 2019)
2.7 Date of Key Manufacturers Enter into Influenza Vaccines Market
2.8 Key Manufacturers Influenza Vaccines Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Global Influenza Vaccines Status and Outlook by Region (2015-2026)
3.1 Global Influenza Vaccines Market Size and CAGR by Region: 2015 VS 2020 VS 2026
3.2 Global Influenza Vaccines Market Size Market Share by Region (2015-2020)
3.2.1 Global Influenza Vaccines Sales Market Share by Region (2015-2020)
3.2.2 Global Influenza Vaccines Revenue Market Share by Region (2015-2020)
3.2.3 Global Influenza Vaccines Sales, Revenue, Price and Gross Margin (2015-2020)
3.3 Global Influenza Vaccines Market Size Market Share by Region (2021-2026)
3.3.1 Global Influenza Vaccines Sales Market Share by Region (2021-2026)
3.3.2 Global Influenza Vaccines Revenue Market Share by Region (2021-2026)
3.3.3 Global Influenza Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
3.4 North America Influenza Vaccines Market Size YoY Growth (2015-2026)
3.4.1 North America Influenza Vaccines Revenue YoY Growth (2015-2026)
3.4.2 North America Influenza Vaccines Sales YoY Growth (2015-2026)
3.5 Asia-Pacific Influenza Vaccines Market Size YoY Growth (2015-2026)
3.5.1 Asia-Pacific Influenza Vaccines Revenue YoY Growth (2015-2026)
3.5.2 Asia-Pacific Influenza Vaccines Sales YoY Growth (2015-2026)
3.6 Europe Influenza Vaccines Market Size YoY Growth (2015-2026)
3.6.1 Europe Influenza Vaccines Revenue YoY Growth (2015-2026)
3.6.2 Europe Influenza Vaccines Sales YoY Growth (2015-2026)
3.7 Latin America Influenza Vaccines Market Size YoY Growth (2015-2026)
3.7.1 Latin America Influenza Vaccines Revenue YoY Growth (2015-2026)
3.7.2 Latin America Influenza Vaccines Sales YoY Growth (2015-2026)
3.8 Middle East and Africa Influenza Vaccines Market Size YoY Growth (2015-2026)
3.8.1 Middle East and Africa Influenza Vaccines Revenue YoY Growth (2015-2026)
3.8.2 Middle East and Africa Influenza Vaccines Sales YoY Growth (2015-2026)
4 Global Influenza Vaccines by Application
4.1 Influenza Vaccines Segment by Application
4.1.1 Adults
4.1.2 Pediatrics
4.2 Global Influenza Vaccines Sales by Application: 2015 VS 2020 VS 2026
4.3 Global Influenza Vaccines Historic Sales by Application (2015-2020)
4.4 Global Influenza Vaccines Forecasted Sales by Application (2021-2026)
4.5 Key Regions Influenza Vaccines Market Size by Application
4.5.1 North America Influenza Vaccines by Application
4.5.2 Europe Influenza Vaccines by Application
4.5.3 Asia-Pacific Influenza Vaccines by Application
4.5.4 Latin America Influenza Vaccines by Application
4.5.5 Middle East and Africa Influenza Vaccines by Application 5 North America Influenza Vaccines Market Size by Country (2015-2026)
5.1 North America Market Size Market Share by Country (2015-2020)
5.1.1 North America Influenza Vaccines Sales Market Share by Country (2015-2020)
5.1.2 North America Influenza Vaccines Revenue Market Share by Country (2015-2020)
5.2 North America Market Size Market Share by Country (2021-2026)
5.2.1 North America Influenza Vaccines Sales Market Share by Country (2021-2026)
5.2.2 North America Influenza Vaccines Revenue Market Share by Country (2021-2026)
5.3 North America Market Size YoY Growth by Country
5.3.1 U.S. Influenza Vaccines Market Size YoY Growth (2015-2026)
5.3.2 Canada Influenza Vaccines Market Size YoY Growth (2015-2026) 6 Europe Influenza Vaccines Market Size by Country (2015-2026)
6.1 Europe Market Size Market Share by Country (2015-2020)
6.1.1 Europe Influenza Vaccines Sales Market Share by Country (2015-2020)
6.1.2 Europe Influenza Vaccines Revenue Market Share by Country (2015-2020)
6.2 Europe Market Size Market Share by Country (2021-2026)
6.2.1 Europe Influenza Vaccines Sales Market Share by Country (2021-2026)
6.2.2 Europe Influenza Vaccines Revenue Market Share by Country (2021-2026)
6.3 Europe Market Size YoY Growth by Country
6.3.1 Germany Influenza Vaccines Market Size YoY Growth (2015-2026)
6.3.2 France Influenza Vaccines Market Size YoY Growth (2015-2026)
6.3.3 U.K. Influenza Vaccines Market Size YoY Growth (2015-2026)
6.3.4 Italy Influenza Vaccines Market Size YoY Growth (2015-2026)
6.3.5 Russia Influenza Vaccines Market Size YoY Growth (2015-2026) 7 Asia-Pacific Influenza Vaccines Market Size by Country (2015-2026)
7.1 Asia-Pacific Market Size Market Share by Country (2015-2020)
7.1.1 Asia-Pacific Influenza Vaccines Sales Market Share by Country (2015-2020)
7.1.2 Asia-Pacific Influenza Vaccines Revenue Market Share by Country (2015-2020)
7.2 Asia-Pacific Market Size Market Share by Country (2021-2026)
7.2.1 Asia-Pacific Influenza Vaccines Sales Market Share by Country (2021-2026)
7.2.2 Asia-Pacific Influenza Vaccines Revenue Market Share by Country (2021-2026)
7.3 Asia-Pacific Market Size YoY Growth by Country
7.3.1 China Influenza Vaccines Market Size YoY Growth (2015-2026)
7.3.2 Japan Influenza Vaccines Market Size YoY Growth (2015-2026)
7.3.3 South Korea Influenza Vaccines Market Size YoY Growth (2015-2026)
7.3.4 India Influenza Vaccines Market Size YoY Growth (2015-2026)
7.3.5 Australia Influenza Vaccines Market Size YoY Growth (2015-2026)
7.3.6 Taiwan Influenza Vaccines Market Size YoY Growth (2015-2026)
7.3.7 Indonesia Influenza Vaccines Market Size YoY Growth (2015-2026)
7.3.8 Thailand Influenza Vaccines Market Size YoY Growth (2015-2026)
7.3.9 Malaysia Influenza Vaccines Market Size YoY Growth (2015-2026)
7.3.10 Philippines Influenza Vaccines Market Size YoY Growth (2015-2026)
7.3.11 Vietnam Influenza Vaccines Market Size YoY Growth (2015-2026) 8 Latin America Influenza Vaccines Market Size by Country (2015-2026)
8.1 Latin America Market Size Market Share by Country (2015-2020)
8.1.1 Latin America Influenza Vaccines Sales Market Share by Country (2015-2020)
8.1.2 Latin America Influenza Vaccines Revenue Market Share by Country (2015-2020)
8.2 Latin America Market Size Market Share by Country (2021-2026)
8.2.1 Latin America Influenza Vaccines Sales Market Share by Country (2021-2026)
8.2.2 Latin America Influenza Vaccines Revenue Market Share by Country (2021-2026)
8.3 Latin America Market Size YoY Growth by Country
8.3.1 Mexico Influenza Vaccines Market Size YoY Growth (2015-2026)
8.3.2 Brazil Influenza Vaccines Market Size YoY Growth (2015-2026)
8.3.3 Argentina Influenza Vaccines Market Size YoY Growth (2015-2026) 9 Middle East and Africa Influenza Vaccines Market Size by Country (2015-2026)
9.1 Middle East and Africa Market Size Market Share by Country (2015-2020)
9.1.1 Middle East and Africa Influenza Vaccines Sales Market Share by Country (2015-2020)
9.1.2 Middle East and Africa Influenza Vaccines Revenue Market Share by Country (2015-2020)
9.2 Middle East and Africa Market Size Market Share by Country (2021-2026)
9.2.1 Middle East and Africa Influenza Vaccines Sales Market Share by Country (2021-2026)
9.2.2 Middle East and Africa Influenza Vaccines Revenue Market Share by Country (2021-2026)
9.3 Middle East and Africa Market Size YoY Growth by Country
9.3.1 Turkey Influenza Vaccines Market Size YoY Growth (2015-2026)
9.3.2 Saudi Arabia Influenza Vaccines Market Size YoY Growth (2015-2026)
9.3.3 U.A.E Influenza Vaccines Market Size YoY Growth (2015-2026)
10 Company Profiles and Key Figures in Influenza Vaccines Business
10.1 AstraZeneca
10.1.1 AstraZeneca Corporation Information
10.1.2 AstraZeneca Description, Business Overview and Total Revenue
10.1.3 AstraZeneca Influenza Vaccines Sales, Revenue and Gross Margin (2015-2020)
10.1.4 AstraZeneca Influenza Vaccines Products Offered
10.1.5 AstraZeneca Recent Development
10.2 CSL
10.2.1 CSL Corporation Information
10.2.2 CSL Description, Business Overview and Total Revenue
10.2.3 CSL Influenza Vaccines Sales, Revenue and Gross Margin (2015-2020)
10.2.5 CSL Recent Development
10.3 GlaxoSmithKline
10.3.1 GlaxoSmithKline Corporation Information
10.3.2 GlaxoSmithKline Description, Business Overview and Total Revenue
10.3.3 GlaxoSmithKline Influenza Vaccines Sales, Revenue and Gross Margin (2015-2020)
10.3.4 GlaxoSmithKline Influenza Vaccines Products Offered
10.3.5 GlaxoSmithKline Recent Development
10.4 Sanofi
10.4.1 Sanofi Corporation Information
10.4.2 Sanofi Description, Business Overview and Total Revenue
10.4.3 Sanofi Influenza Vaccines Sales, Revenue and Gross Margin (2015-2020)
10.4.4 Sanofi Influenza Vaccines Products Offered
10.4.5 Sanofi Recent Development
10.5 Altimmune
10.5.1 Altimmune Corporation Information
10.5.2 Altimmune Description, Business Overview and Total Revenue
10.5.3 Altimmune Influenza Vaccines Sales, Revenue and Gross Margin (2015-2020)
10.5.4 Altimmune Influenza Vaccines Products Offered
10.5.5 Altimmune Recent Development
10.6 BionVax
10.6.1 BionVax Corporation Information
10.6.2 BionVax Description, Business Overview and Total Revenue
10.6.3 BionVax Influenza Vaccines Sales, Revenue and Gross Margin (2015-2020)
10.6.4 BionVax Influenza Vaccines Products Offered
10.6.5 BionVax Recent Development
10.7 FluGen
10.7.1 FluGen Corporation Information
10.7.2 FluGen Description, Business Overview and Total Revenue
10.7.3 FluGen Influenza Vaccines Sales, Revenue and Gross Margin (2015-2020)
10.7.4 FluGen Influenza Vaccines Products Offered
10.7.5 FluGen Recent Development
10.8 FOLIA BIOTECH
10.8.1 FOLIA BIOTECH Corporation Information
10.8.2 FOLIA BIOTECH Description, Business Overview and Total Revenue
10.8.3 FOLIA BIOTECH Influenza Vaccines Sales, Revenue and Gross Margin (2015-2020)
10.8.4 FOLIA BIOTECH Influenza Vaccines Products Offered
10.8.5 FOLIA BIOTECH Recent Development
10.9 Genentech
10.9.1 Genentech Corporation Information
10.9.2 Genentech Description, Business Overview and Total Revenue
10.9.3 Genentech Influenza Vaccines Sales, Revenue and Gross Margin (2015-2020)
10.9.4 Genentech Influenza Vaccines Products Offered
10.9.5 Genentech Recent Development
10.10 Green Cross
10.10.1 Company Basic Information, Manufacturing Base and Competitors
10.10.2 Influenza Vaccines Product Category, Application and Specification
10.10.3 Green Cross Influenza Vaccines Sales, Revenue, Price and Gross Margin (2015-2020)
10.10.4 Main Business Overview
10.10.5 Green Cross Recent Development
10.11 Medicago
10.11.1 Medicago Corporation Information
10.11.2 Medicago Description, Business Overview and Total Revenue
10.11.3 Medicago Influenza Vaccines Sales, Revenue and Gross Margin (2015-2020)
10.11.4 Medicago Influenza Vaccines Products Offered
10.11.5 Medicago Recent Development
10.12 Moderna Therapeutics
10.12.1 Moderna Therapeutics Corporation Information
10.12.2 Moderna Therapeutics Description, Business Overview and Total Revenue
10.12.3 Moderna Therapeutics Influenza Vaccines Sales, Revenue and Gross Margin (2015-2020)
10.12.4 Moderna Therapeutics Influenza Vaccines Products Offered
10.12.5 Moderna Therapeutics Recent Development
10.13 Novavax
10.13.1 Novavax Corporation Information
10.13.2 Novavax Description, Business Overview and Total Revenue
10.13.3 Novavax Influenza Vaccines Sales, Revenue and Gross Margin (2015-2020)
10.13.4 Novavax Influenza Vaccines Products Offered
10.13.5 Novavax Recent Development
10.14 Shijiazhuang Yiling Pharmaceutical
10.14.1 Shijiazhuang Yiling Pharmaceutical Corporation Information
10.14.2 Shijiazhuang Yiling Pharmaceutical Description, Business Overview and Total Revenue
10.14.3 Shijiazhuang Yiling Pharmaceutical Influenza Vaccines Sales, Revenue and Gross Margin (2015-2020)
10.14.4 Shijiazhuang Yiling Pharmaceutical Influenza Vaccines Products Offered
10.14.5 Shijiazhuang Yiling Pharmaceutical Recent Development
10.15 SK Chemicals
10.15.1 SK Chemicals Corporation Information
10.15.2 SK Chemicals Description, Business Overview and Total Revenue
10.15.3 SK Chemicals Influenza Vaccines Sales, Revenue and Gross Margin (2015-2020)
10.15.4 SK Chemicals Influenza Vaccines Products Offered
10.15.5 SK Chemicals Recent Development
10.16 UNM Pharma
10.16.1 UNM Pharma Corporation Information
10.16.2 UNM Pharma Description, Business Overview and Total Revenue
10.16.3 UNM Pharma Influenza Vaccines Sales, Revenue and Gross Margin (2015-2020)
10.16.4 UNM Pharma Influenza Vaccines Products Offered
10.16.5 UNM Pharma Recent Development
10.17 Vaccitech
10.17.1 Vaccitech Corporation Information
10.17.2 Vaccitech Description, Business Overview and Total Revenue
10.17.3 Vaccitech Influenza Vaccines Sales, Revenue and Gross Margin (2015-2020)
10.17.4 Vaccitech Influenza Vaccines Products Offered
10.17.5 Vaccitech Recent Development
10.18 Vaxart
10.18.1 Vaxart Corporation Information
10.18.2 Vaxart Description, Business Overview and Total Revenue
10.18.3 Vaxart Influenza Vaccines Sales, Revenue and Gross Margin (2015-2020)
10.18.4 Vaxart Influenza Vaccines Products Offered
10.18.5 Vaxart Recent Development
10.19 Vaxine Pty
10.19.1 Vaxine Pty Corporation Information
10.19.2 Vaxine Pty Description, Business Overview and Total Revenue
10.19.3 Vaxine Pty Influenza Vaccines Sales, Revenue and Gross Margin (2015-2020)
10.19.4 Vaxine Pty Influenza Vaccines Products Offered
10.19.5 Vaxine Pty Recent Development
10.20 Visterra
10.20.1 Visterra Corporation Information
10.20.2 Visterra Description, Business Overview and Total Revenue
10.20.3 Visterra Influenza Vaccines Sales, Revenue and Gross Margin (2015-2020)
10.20.4 Visterra Influenza Vaccines Products Offered
10.20.5 Visterra Recent Development
11 Influenza Vaccines Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Influenza Vaccines Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Influenza Vaccines Industrial Chain Analysis
11.4 Market Opportunities, Challenges, Risks and Influences Factors Analysis
11.4.1 Market Opportunities and Drivers
11.4.2 Market Challenges
11.4.3 Market Risks
11.4.4 Porter's Five Forces Analysis
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Distributors
12.3 Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology/Research Approach
14.1.1 Research Programs/Design
14.1.2 Market Size Estimation
14.1.3 Market Breakdown and Data Triangulation
14.2 Data Source
14.2.1 Secondary Sources
14.2.2 Primary Sources
14.3 Author Details
14.4 Disclaimer
Enquire for customization in Report @ https://www.qyresearch.com/customize-request/form/1540857/global-influenza-vaccines-market
Report Objectives
o To carefully analyze and estimate the size of the global Influenza Vaccines market.
o To clearly segment the global Influenza Vaccines market and estimate the market size of the segments.
o To provide details about key strategies adopted by leading players of the global Influenza Vaccines market.
o To help readers understand the current and future market scenarios.
o To provide information about the latest trends of the global Influenza Vaccines market and its key segments.
o To assess the contribution of each region or country to the global Influenza Vaccines market.
o To provide information on important drivers, restraints, and opportunities of the global Influenza Vaccines market.
o To accurately calculate the market shares of key segments, regions, and companies in the global Influenza Vaccines market.
About Us:
QYResearch always pursuits high product quality with the belief that quality is the soul of business. Through years of effort and supports from the huge number of customer supports, QYResearch consulting group has accumulated creative design methods on many high-quality markets investigation and research team with rich experience. Today, QYResearch has become a brand of quality assurance in the consulting industry.
Contact Us:-
QY Research, INC.
17890 Castleton,
Suite 218,
Los Angeles, CA - 91748
USA: +1 626 295 2442
Email:
enquiry@qyresearch.com
Web:
http://www.qyresearch.com
-
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Influenza Vaccines Market Growth by Top Companies, Trends by Types and Application, Forecast to 2026| here
News-ID: 2028505 • Views: …
More Releases from QY Research
Steel Floor Panels Market to Reach USD 17,565 Million by 2031 Top 20 Company Glo …
Steel floor panels cover a range of products used in commercial, industrial and data-center construction: profiled steel decking for composite slabs, galvanized or coated steel raised-access panels for server rooms and offices, and engineered steel mezzanine/industrial floor panels for warehouses and manufacturing plants. They are selected for strength-to-weight ratio, speed of installation, fire performance (when specified with appropriate infill), recyclability and long service life. Product differentiation is driven by profile…
Electronic Home Scales Market to Reach USD 4,138 Million by 2031 Top 15 Company …
Electronic home scales, often placed in bathrooms or kitchens, are digital devices designed to measure body weight and, in many cases, additional parameters such as body fat, water content, muscle mass, and BMI using technologies like strain gauges or bio-impedance. These devices have transcended simple weight measurement to become central to consumer health tracking, fitness routines, and increasingly integrated via Bluetooth or Wi-Fi with mobile apps and smart home ecosystems.…
Disposable Medical Probe Covers Market to Reach CAGR 5,5% by 2031 Top 10 Company …
Disposable medical probe covers (commonly sold as ultrasound probe covers, transducer sheaths, endocavity kits and related disposable sheathing products) are single-use barriers placed over diagnostic and interventional probes to reduce cross-contamination and support infection-control workflows in ultrasound, transesophageal echo (TEE), endocavity and certain interventional procedures. They are manufactured in a range of formats from thin polyethylene sleeves and rolled covers for external probes to individually packaged sterile endocavity kits that…
Global and U.S. Vinylcyclohexene Dioxide Market Report, Published by QY Research …
Vinylcyclohexene Dioxide (VCHD) is a low-viscosity aliphatic diepoxide used as a reactive diluent and crosslinking agent in epoxy resins, coatings, adhesives, and electrical insulation systems. With two oxirane groups attached to a cycloaliphatic backbone, it offers excellent thermal stability, chemical resistance, and dielectric strength, making it suitable for high-performance composites and electronic encapsulation.
https://www.qyresearch.com/reports/4934028/vinylcyclohexene-dioxide
The global market for Vinylcyclohexene Dioxide is projected at USD 86 million in 2024, growing at a…
More Releases for Vaccines
Vaccines Market: Information by Type (Monovalent Vaccines, Multivalent Vaccines) …
Till date, vaccines have majorly contributed to eradicating several severe diseases—smallpox and polio—from the face of the earth. During 1980–90, around millions of people died due to smallpox. Moreover, after the introduction of a worldwide End Polio Campaign, the number of polio cases has reduced to 407 in 2013 from 350,000 in 1988, the CDC.
Global vaccines market was valued at USD 30.2 billion in 2018 and is expected to…
Global Pet Vaccine Market By Type (Attenuated Live Vaccines, Conjugate Vaccines, …
The Global Pet Vaccine Market 2020 report implement in-depth research of the industry with a focus on the current market trends future prospects. The Global Pet Vaccine Market report aims to provide an overview of Pet Vaccine Market players with detailed market segmentation by product, application and geographical region. It also provides market share and size, revenue forecast, growth opportunity. The most recent trending report Worldwide Pet Vaccine Market Economy…
Animal Vaccines Market Report 2018: Segmentation by Product (Attenuated Vaccines …
Global Animal Vaccines market research report provides company profile for Merck & Co., Inc., Zoetis Inc., Ceva Sant Animale, Sanofi S.A., Romvac, Vaxxinova, Biovac, Merial, Anicon Labor GmbH, Nexvet, PHL Associates, Inc., Hygieia Biological Laboratories, Colorado Serum Company, Pfizer, Arko Laboratories, Ltd. Others.
This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in…
Vaccines & Vaccination Market Report 2018: Segmentation by Type (Subunit vaccine …
Global Vaccines & Vaccination market research report provides company profile for CSL, Emergent BioSolutions, GSK, Johnson & Johnson, Pfizer, Merck, Sanofi, Abbott, AstraZeneca, Bavarian Nordic, Novartis, Bharat Biotech, Bio-Med and Others.
This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for the year…
Global Veterinary Vaccines Market, By Technology Type (Inactivated Vaccines, Tox …
Veterinary/Animal Vaccines – Ensure good health of human’s best friends
Veterinary vaccination enhances the health of animals, thus improving their life expectancies. Most common veterinary vaccines include those for rabies, E. coli, distemper, hepatitis rotavirus, parvovirus, brucellosis, and pinkeye. Various diseases such as foot-and-mouth disease and influenza adversely affect livestock across the globe. Economic losses due to death of livestock is significant as it impacts the supply of dairy products, meat,…
Global Veterinary Vaccines Market, By Technology Type (Inactivated Vaccines, Tox …
Veterinary/Animal Vaccines – Ensure good health of human’s best friends
Veterinary vaccination enhances the health of animals, thus improving their life expectancies. Most common veterinary vaccines include those for rabies, E. coli, distemper, hepatitis rotavirus, parvovirus, brucellosis, and pinkeye. Various diseases such as foot-and-mouth disease and influenza adversely affect livestock across the globe. Economic losses due to death of livestock is significant as it impacts the supply of dairy products, meat,…
